1. Home
  2. LXRX vs BBCP Comparison

LXRX vs BBCP Comparison

Compare LXRX & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • BBCP
  • Stock Information
  • Founded
  • LXRX 1995
  • BBCP 1983
  • Country
  • LXRX United States
  • BBCP United States
  • Employees
  • LXRX 103
  • BBCP N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • BBCP Engineering & Construction
  • Sector
  • LXRX Health Care
  • BBCP Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • BBCP Nasdaq
  • Market Cap
  • LXRX 388.6M
  • BBCP 360.0M
  • IPO Year
  • LXRX 2000
  • BBCP 2017
  • Fundamental
  • Price
  • LXRX $1.07
  • BBCP $6.84
  • Analyst Decision
  • LXRX Buy
  • BBCP Buy
  • Analyst Count
  • LXRX 4
  • BBCP 2
  • Target Price
  • LXRX $3.67
  • BBCP $7.00
  • AVG Volume (30 Days)
  • LXRX 3.5M
  • BBCP 95.3K
  • Earning Date
  • LXRX 08-06-2025
  • BBCP 09-03-2025
  • Dividend Yield
  • LXRX N/A
  • BBCP N/A
  • EPS Growth
  • LXRX N/A
  • BBCP N/A
  • EPS
  • LXRX N/A
  • BBCP 0.23
  • Revenue
  • LXRX $31,213,000.00
  • BBCP $401,503,000.00
  • Revenue This Year
  • LXRX N/A
  • BBCP N/A
  • Revenue Next Year
  • LXRX N/A
  • BBCP $4.28
  • P/E Ratio
  • LXRX N/A
  • BBCP $30.18
  • Revenue Growth
  • LXRX 1251.21
  • BBCP N/A
  • 52 Week Low
  • LXRX $0.28
  • BBCP $4.78
  • 52 Week High
  • LXRX $2.25
  • BBCP $9.68
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 52.30
  • BBCP 53.83
  • Support Level
  • LXRX $1.00
  • BBCP $6.84
  • Resistance Level
  • LXRX $1.11
  • BBCP $7.06
  • Average True Range (ATR)
  • LXRX 0.10
  • BBCP 0.23
  • MACD
  • LXRX -0.03
  • BBCP -0.02
  • Stochastic Oscillator
  • LXRX 16.28
  • BBCP 44.23

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About BBCP Concrete Pumping Holdings Inc.

Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.

Share on Social Networks: